This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: The Rockefeller University, Columbia University, Massachusetts Institute of Technology. Active years: 1999-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (1999 - 2002)
- Riverdale, NY (US) (2011 - 2017)
Company Filing History:
3 out of 751 
1 out of 2,560 
1 out of 8,594 
Years Active: 1999-2017
Title: The Innovative Mind of Maria Karayiorgou: Pioneering Treatments for Schizophrenia and Cognitive Disorders
Introduction:
Maria Karayiorgou, a distinguished inventor based in Riverdale, NY, has made significant contributions to the field of neuroscience through her groundbreaking research and patented inventions. With a strong focus on enhancing neuronal connectivity and tackling disorders like schizophrenia, Karayiorgou's work stands at the forefront of innovative medical treatments.
Latest Patents:
Karayiorgou's latest patents demonstrate her dedication to advancing treatments for schizophrenia and cognitive dysfunction. One of her notable inventions involves an inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction, known as 'Mirta22.' This protein inhibits the formation of neural connections and serves as a potential target for treating schizophrenia and other disorders related to neural connectivity. Another patent focuses on identifying calcineurin activators for the treatment of schizophrenia, providing valuable insights into diagnostic methods and potential therapeutic compounds.
Career Highlights:
Throughout her career, Maria Karayiorgou has been associated with esteemed research institutions such as The Rockefeller University and Columbia University in the City of New York. Her research has garnered international recognition for its impact on understanding and treating complex neurological conditions. With four patents to her name, Karayiorgou continues to push boundaries in the field of neuroscience and mental health.
Collaborations:
Karayiorgou has collaborated closely with accomplished researchers like Joseph A Gogos and Bin Xu, pooling their expertise to drive forward innovative solutions in the realm of neuroscience. These collaborations have been instrumental in advancing our understanding of schizophrenia susceptibility and cognitive disorders, paving the way for novel treatment modalities.
Conclusion:
In conclusion, Maria Karayiorgou's inventive spirit and commitment to improving patients' lives through pioneering treatments for schizophrenia and cognitive dysfunction make her a standout figure in the field of neuroscience. Her patented inventions represent significant milestones in the quest for enhanced neural connectivity and innovative approaches to treating complex brain disorders. As she continues her research endeavors, Karayiorgou's impact on the medical landscape is sure to resonate for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile